Literature DB >> 3897511

Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.

R Venkataramanan, R J Ptachcinski, G J Burckart, S Yang, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3897511      PMCID： PMC3022509          DOI： 10.1002/jps.2600740824

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  11 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients.

Authors:  G Burckart; T Starzl; L Williams; A Sanghvi; C Gartner; R Venkataramanan; B Zitelli; J Malatack; A Urbach; W Diven; R Ptachcinski; B Shaw; S Iwatsuki
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

3.  THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.

Authors:  S E Bradley; F J Ingelfinger; G P Bradley; J J Curry
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

4.  Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment.

Authors:  E Langhoff; S Madsen
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

5.  Ketoconazole, cyclosporin metabolism, and renal transplantation.

Authors:  R M Ferguson; D E Sutherland; R L Simmons; J S Najarian
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

6.  Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.

Authors:  B A Reitz; C P Bieber; A A Raney; J L Pennock; S W Jamieson; P E Oyer; E B Stinson
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.

Authors:  P A Keown; C R Stiller; A L Laupacis; W Howson; R Coles; M Stawecki; J Koegler; G Carruthers; N McKenzie; N R Sinclair
Journal:  Transplant Proc       Date:  1982-12       Impact factor: 1.066

8.  Liver transplantation with use of cyclosporin a and prednisone.

Authors:  T E Starzl; G B Klintmalm; K A Porter; S Iwatsuki; G P Schröter
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

9.  Liquid-chromatographic determination of cyclosporin A in blood and plasma.

Authors:  R J Sawchuk; L L Cartier
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

10.  Cyclosporin A for the treatment of graft-versus-host disease in man.

Authors:  R L Powles; A J Barrett; H Clink; H E Kay; J Sloane; T J McElwain
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321
View more
  7 in total

1.  Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.

Authors:  J Grevel; E Nüesch; E Abisch; K Kutz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers.

Authors:  J P Reymond; J L Steimer; W Niederberger
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

Review 3.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  In vivo model for ciclosporin intestinal absorption in lipid vehicles.

Authors:  J P Reymond; H Sucker; J Vonderscher
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

Review 5.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

6.  Cyclosporin-erythromycin interaction in renal transplant patients.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

7.  Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.

Authors:  M J E Brill; P A J Välitalo; A S Darwich; B van Ramshorst; H P A van Dongen; A Rostami-Hodjegan; M Danhof; C A J Knibbe
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.